GALDERMA GROUP AG (GALDY) Stock Forecast

NYSE: GALDYAnalyst ratings, price target and estimates.

GALDY analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
5.00 / 5 from 1 analysts
Price target
$50.08
average of analyst targets
Upside to target
+17.9%
from the latest close
Next earnings
—
52-week range
$34.63 – $46.19

GALDY analyst ratings

1 analysts
Strong buy
1100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

GALDY price target

Price $42.47Target $50.08
52-week low $34.6352-week high $46.19

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

GALDY earnings per share estimates

GALDERMA GROUP AG EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current fiscal year (2026)$3.51$3.51$3.51——1
Next fiscal year (2027)$5.16$5.16$5.16$3.51+47.2%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

GALDY revenue estimates

GALDERMA GROUP AG revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$1.55B$1.53B$1.57B+20.5%3
Current fiscal year (2026)$6.42B$6.39B$6.46B+23.2%14
Next fiscal year (2027)$7.54B$7.49B$7.92B+17.9%17

GALDY EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

GALDY revenue: reported and forecast

Reported revenueEstimate (average; low–high)

GALDY EPS estimate revisions

GALDERMA GROUP AG EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current fiscal year (2026)$3.44$3.44$3.60$3.52$3.51+1.8%0 up · 1 down
Next fiscal year (2027)$5.33$5.33$5.33$5.21$5.16−3.1%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

What analysts expect from GALDY

1 analysts cover GALDERMA GROUP; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $50.08, 17.9% above the latest close of $42.47. Analysts expect earnings of $3.51 per share for 2026. For 2027 the average estimate is $5.16 per share on revenue of $7.5 billion.

Related: GALDY income statement, GALDY key metrics, GALDY chart. See the GALDY stock overview for the latest quote and news.

GALDY forecast FAQ

What is GALDERMA GROUP's price target?

The average analyst price target for GALDERMA GROUP is $50.08, 17.9% above the latest close of $42.47.

Is GALDERMA GROUP a buy, hold or sell?

Of 1 analysts covering GALDERMA GROUP, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is GALDERMA GROUP's EPS forecast?

Analysts forecast $3.51 per share for 2026 (range $3.51 to $3.51); for 2027 the estimate is $5.16.

What is GALDERMA GROUP's revenue forecast?

The average revenue estimate for 2026 is $6.4 billion, growth of 23.2%; for 2027 it is $7.5 billion.

Drug Manufacturers - Specialty & Generic: forecast